12
2023
-
01
Hubei Guangchen Pharmaceutical Allopurinol API Transfer A
Author:
On January 12, 2023, our company transferred allopurinol API to A, and the packaging specifications of this product are: 1kg/barrel, 5kg/barrel, 10kg/barrel, 25kg/barrel, or can be provided according to customer requirements.
On January 12, 2023, our company transferred allopurinol API to A, and the packaging specifications of this product are: 1kg/barrel, 5kg/barrel, 10kg/barrel, 25kg/barrel, or can be provided according to customer requirements.
Allopurinol and its metabolites can inhibit xanthine oxidase, prevent hypoxanthine and xanthine from converting to uric acid, thereby reducing the concentration of uric acid in the blood, reducing the deposition of uric acid salts in bones, joints, and kidneys, and can inhibit the production of uric acid synthesis.
Related News
On November 7, 2024, the Emergency Management Bureau of Yichang High-tech Zone issued a three-level safety production standardization enterprise (medicine) certificate to our company.
2024-11-13
On October 18, 2024, Director Xu Guangpin of the Biological Park Management Committee and his party visited our company for research.
2024-10-18
Making Good Medicines for Health and Life
Customer Service Hotline
Official website: www.hbgcyy.cn
Address: No. 19, Biopark 2nd Road, Biopark Industrial Park, High-tech Zone, Yichang City.
This website supports both IPV4 and IPV6 access.
Copyright © 2023 Guangchen Pharmaceutical ALL RIGHTS RESERVED.